RCT of TAE Simultaneously Combined Thermal Ablation for Large Hepatocellular Carcinoma
Status:
Recruiting
Trial end date:
2022-12-01
Target enrollment:
Participant gender:
Summary
This study intends to evaluate the efficacy and safety of Transarterial embolization (TAE)
simultaneously combined with thermal ablation for large hepatocellular carcinoma (HCC). Half
participants will receive TAE simultaneously combined with thermal ablation and the other
half receive TACE sequentially combined with thermal ablation, which is a conventional
treatment for HCC patients.
Phase:
N/A
Details
Lead Sponsor:
Sun Yat-sen University
Collaborators:
First Affiliated Hospital, Sun Yat-Sen University Guangdong General Hospital Guangdong Provincial People's Hospital Sixth Affiliated Hospital, Sun Yat-sen University Sun Yat-Sen Memorial Hospital of Sun Yat-Sen University Third Affiliated Hospital, Sun Yat-Sen University